SIRT3 and lung carcinoma: Honokiol blocks the growth of lung cancer cells by activating SIRT3 to inhibit HIF-1α expression, and also be used as adjuvant chemotherapy to prevent doxorubicin-induced cardiotoxicity in tumors transplanted mice (113, 114).